DANVERS, Mass. (June 25, 2024) – Beckman Coulter
Genomics introduces the SPRIworks Fragment Library System II.
The second release in the SPRIworks product line automates the
preparation of fragment libraries for the Roche GS FLX* DNA
Sequencer, and can prepare up to 10 DNA libraries in 3.5 hours with
high reproducibility and consistency.
SPRIworks Fragment Library System II, developed by Beckman
Coulter Genomics, utilizes Solid Phase Reversible Immobilization
(SPRI) paramagnetic bead-based technology. By using SPRI
chemistry and Beckman Coulter automation, SPRIworks System II
eliminates manual library construction, allowing researchers to
perform other laboratory processes.
SPRIworks System II follows the introduction earlier this year
of SPRIworks System I, which prepares DNA fragment libraries for
analysis on the Illumina GA sequencing system. SPRIworks
Fragment Library Systems I and II are based on the same benchtop
platform. By using cartridges and method cards specific to each
sequencing system, fragment libraries can be prepared for both the
Roche GS FLX and Illumina GA sequencers on a single instrument.
"The introduction of SPRIworks System II enables us to more
fully serve customers who use DNA fragment libraries," commented
Julie Moore, director of marketing for Beckman Coulter
Genomics. "Automating the library construction process for
these two leading sequencing platforms offers significant time and
labor savings by simplifying the next generation sequencing
workflow."
About Beckman Coulter Genomics
Beckman Coulter Genomics, headquartered in Danvers, Massachusetts,
is a leading provider of genomic services and nucleic acid
purification products, serving life-science researchers and the
pharmaceutical industry throughout the world. The company, a
wholly owned subsidiary of Beckman Coulter, was created by
combining Beckman Coulter’s Agencourt Bioscience with the
newly acquired Cogenics. By providing technical expertise,
combined with personalized service, Beckman Coulter Genomics
delivers the highest quality data, robust analyses and innovative
thinking. For more information, visit www.beckmangenomics.com.
About Beckman Coulter, Inc.
Beckman Coulter, Inc., based in Orange County, California,
develops, manufactures and markets products that simplify,
automate and innovate complex biomedical tests. More
than 200,000 Beckman Coulter systems operate in laboratories around
the world, supplying critical information for improving patient
health and reducing the cost of care. Recurring revenue,
consisting of consumable supplies (including reagent test kits),
service and operating-type lease payments, represent about 80
percent of the company's 2009 revenue of $3.3 billion. For more
information, visit www.beckmancoulter.com.
*GS FLX is a trademark of Roche.
Beckman Coulter, SPRI, Agencourt and the stylized logo are
registered trademarks of Beckman Coulter, Inc
SOURCE